Karl F Mann (Karl Mann)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 15

Top Venues

Alcoholism, clinical and experimental research

Alcohol, clinical & experimental research

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology

Journal of behavioral addictions

Central Institute of Mental Health (CIMH)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Central Institute of Mental Health (CIMH) Mar 01 1999 - Mar 01 2014

Germany

Director :: Dept. of Addictive Behavior & Addiction Medicine

Central Institute of Mental Health (CIMH) Mar 01 1999 - Mar 01 2014

Germany

Director :: Dept. of Addictive Behavior & Addiction Medicine

Publications

Felicia R Tuchman, Kevin A Hallgren, Dylan K Richards, Arnie Aldridge, Raymond K Anton, Henri-Jean Aubin, Henry R Kranzler, Karl F Mann, Stephanie S O'Malley, Katie A Witkiewitz
Reductions in WHO risk drinking levels correlate with alcohol craving among individuals with alcohol use disorder. Alcohol, clinical & experimental research 48 (2) (2024)
Felicia R Tuchman, Kevin A Hallgren, Dylan K Richards, Arnie Aldridge, Raymond K Anton, Henri-Jean Aubin, Henry R Kranzler, Karl F Mann, Stephanie S O'Malley, Katie A Witkiewitz
Reductions in WHO risk drinking levels correlate with alcohol craving among individuals with alcohol use disorder. Alcohol, clinical & experimental research 48 (2) (2024)
Felicia R Tuchman, Kevin A Hallgren, Dylan K Richards, Arnie Aldridge, Raymond K Anton, Henri-Jean Aubin, Henry R Kranzler, Karl F Mann, Stephanie S O'Malley, Katie A Witkiewitz
Reductions in WHO risk drinking levels correlate with alcohol craving among individuals with alcohol use disorder. Alcohol, clinical & experimental research (2023)
Kai W Müller, Michael Dreier, Manfred E Beutel, Christian Ruckes, Anil Batra, Karl F Mann, Michael Musalek, Klaus Wölfling
The impact of life satisfaction in the treatment of gaming disorder and other internet use disorders: Results from a randomized controlled trial. Journal of behavioral addictions (2023)
Felicia R Tuchman, Kevin A Hallgren, Dylan K Richards, Arnie Aldridge, Raymond K Anton, Henri-Jean Aubin, Henry R Kranzler, Karl F Mann, Stephanie S O'Malley, Katie A Witkiewitz
Reductions in WHO risk drinking levels correlate with alcohol craving among individuals with alcohol use disorder. Alcohol, clinical & experimental research (2023)
Sarah Gerhardt, Damian Karl, Karl F Mann, Falk Kiefer, Sabine Vollstädt-Klein
Association Between Functional and Structural Brain Connectivity of the Default Mode Network in Non-treatment Seeking Individuals With Alcohol Use Disorder. Alcohol and alcoholism (Oxford, Oxfordshire) 57 (5) (2022)
Joanna M Biernacka, Brandon J Coombes, Anthony Batzler, Ada Man-Choi Ho, Jennifer R Geske, Joseph Frank, Colin A Hodgkinson, Michelle Skime, Colin Colby, Lea Zillich, Sofia Pozsonyiova, Ming-Fen Ho, Falk Kiefer, Marcella D C Rietschel, Richard Weinshilboum, Stephanie S O'Malley, Karl F Mann, Raymond K Anton, David Goldman, Victor M Karpyak
Genetic contributions to alcohol use disorder treatment outcomes: a genome-wide pharmacogenomics study. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 46 (12) (2021)
Justin R Knox, Jennifer Scodes, Katie A Witkiewitz, Henry R Kranzler, Karl F Mann, Stephanie S O'Malley, Melanie Wall, Raymond K Anton, Deborah S Hasin, null null
Reduction in World Health Organization Risk Drinking Levels and Cardiovascular Disease. Alcoholism, clinical and experimental research 44 (8) (2020)
Katie A Witkiewitz, Daniel E Falk, Raye Z Litten, Deborah S Hasin, Henry R Kranzler, Karl F Mann, Stephanie S O'Malley, Raymond K Anton
Maintenance of World Health Organization Risk Drinking Level Reductions and Posttreatment Functioning Following a Large Alcohol Use Disorder Clinical Trial. Alcoholism, clinical and experimental research 43 (5) (2019)
Raymond K Anton, Katie A Witkiewitz, Daniel E Falk, Raye Litten, Deborah Hasin, Karl F Mann, Stephanie O'Malley, null null
Response to Dr. Mark Litt's Commentary. Alcoholism, clinical and experimental research 43 (10) (2019)
Katie A Witkiewitz, Corey R Roos, Karl F Mann, Henry R Kranzler
Advancing Precision Medicine for Alcohol Use Disorder: Replication and Extension of Reward Drinking as a Predictor of Naltrexone Response. Alcoholism, clinical and experimental research 43 (11) (2019)
Karl F Mann, Corey R Roos, Katie A Witkiewitz
Response to Letter to Editor (Precision medicine in alcohol dependence: evidence of efficacy and initial support for comparative effectiveness). Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 43 (9) (2018)
Justin Knox, Melanie Wall, Katie A Witkiewitz, Henry R Kranzler, Daniel E Falk, Raye Litten, Karl F Mann, Stephanie S O'Malley, Jennifer Scodes, Raymond K Anton, Deborah S Hasin, null null
Reduction in Nonabstinent WHO Drinking Risk Levels and Change in Risk for Liver Disease and Positive AUDIT-C Scores: Prospective 3-Year Follow-Up Results in the U.S. General Population. Alcoholism, clinical and experimental research 42 (11) (2018)
Katie A Witkiewitz, Henry R Kranzler, Kevin A Hallgren, Stephanie S O'Malley, Daniel E Falk, Raye Z Litten, Deborah S Hasin, Karl F Mann, Raymond K Anton
Drinking Risk Level Reductions Associated with Improvements in Physical Health and Quality of Life Among Individuals with Alcohol Use Disorder. Alcoholism, clinical and experimental research 42 (12) (2018)
Henri-Jean Aubin, Karl F Mann
Medication Development: Reducing Casualties in the Valley of Death and Providing Support for Survivors. Alcoholism, clinical and experimental research 43 (1) (2018)

Karl F Mann.css-eqlu8i{font-size:small;padding-left:4px;} (Karl Mann)

Publication Activity (10 Years)

Top Topics

Top Venues

Karl F Mann (Karl Mann)